Renagel
Product Images NDC 17856-0021

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Renagel (NDC 17856-0021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Chemical Structure Of Sevelamer Hydrochloride (Renagel Figure 1)

Figure 1. Chemical Structure Of Sevelamer Hydrochloride (Renagel Figure 1)
Chemical structure diagram showing the polymeric components of the active ingredient in Renagel by Atlantic Biologicals Corps. The structure includes repeating units with amine hydrochloride groups and hydroxyl substitutions, indicating a polymeric compound.*
FDA Label Image

Figure 2. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Renagel Figure 2)

Figure 2. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Renagel Figure 2)
A Kaplan-Meier style cumulative distribution plot depicting the percentage of patients achieving various levels of reduction in serum phosphorus (mg/dL). Two lines represent treatment groups: Sevelamer Hydrochloride and Active Control, showing comparative effectiveness in reducing serum phosphorus levels from baseline.*
FDA Label Image

Figure 3. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Renagel Figure 3)

Figure 3. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Renagel Figure 3)
A line graph showing phosphorus change from baseline over a 52-week study period. The x-axis represents study weeks, and the y-axis shows phosphorus change values. Two treatments are compared: 'Sevelamer Hydrochloride' indicated by black circles, and 'Active-Control' indicated by red squares, showing trends in phosphorus level changes over time.*
FDA Label Image

Label Image (Rspl17856 0021)

Label Image (Rspl17856 0021)
Label for Renagel (sevelamer hydrochloride) 800 mg tablet, Rx only, distributed by Atlantic Biologicals. The label includes an expiration date of 10/07/2014, lot number, manufacturer Genzyme, and a barcode with NDC 17856-0021. Packaging is by Udose in Miami, FL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.